Drug · DIN 02492482
AG-RIZATRIPTAN ODT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 6, 2021; first marketed August 6, 2021.
- Drug Identification Number (DIN)
- 02492482
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 23, 2019: NOC 22680Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named AG-RIZATRIPTAN ODT
- DIN 02492490 · Marketed